T cells that recognize HER2 teceptor may prevent HER2+ breast cancer recurrence
Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient's immune system—a weakness that in principle could be corrected with a HER2-targeted ...
Dec 30, 2015
0
53